Lasisi Akeem O, Bademci Guney, Foster Joseph, Blanton Susan, Tekin Mustafa
Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA; Department of Otorhinolaryngology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Int J Pediatr Otorhinolaryngol. 2014 Nov;78(11):1870-3. doi: 10.1016/j.ijporl.2014.08.014. Epub 2014 Aug 23.
Little is known about the molecular epidemiology of deafness in sub-Saharan Africa (SSA). Even in Nigeria, the most populous African nation, no genetic studies of deafness have been conducted. This pioneering work aims at investigating the frequencies of gene mutations relatively common in other parts of the world (i.e. those in GJB2, GJB6, and mitochondrial DNA) among subjects from Nigeria with hearing loss (HL) with no evidence of acquired pathology or syndromic findings. In addition, we review the literature on the genetics of deafness in SSA.
We evaluated 81 unrelated deaf probands from the Yoruba tribe residing in Ibadan, a suburban city in Nigeria, for the aetiology of their deafness. Subjects underwent genetic testing if their history was negative for an environmental cause and physical examination did not find evidence of a syndrome. Both exons of GJB2 and mitochondrial DNA flanking the 1555A>G mutations were PCR-amplified followed by Sanger sequencing. GJB6 deletions were screened via quantitative PCR.
We identified 44 probands who had nonsyndromic deafness with no environmental cause. The age at study time ranged between 8 months and 45 years (mean=24 years) and age at onset was congenital or prelingual (<age 2 years) in 37 (84%) probands and postlingual in 7 (16%) probands. Among these, 35 probands were the only affected members of their families (simplex cases), while there were at least two affected family members in nine cases (multiplex). Molecular analyses did not show a pathogenic variant in any one of the 44 probands studied.
GJB2, GJB6 and mitochondrial DNA 1555A>G mutations were not found among this initial cohort of the deaf in Nigeria. This makes imperative the search for other genes in the aetiology of HL in this population.
关于撒哈拉以南非洲地区(SSA)耳聋的分子流行病学知之甚少。即使在非洲人口最多的国家尼日利亚,也尚未开展过耳聋的基因研究。这项开创性工作旨在调查在世界其他地区相对常见的基因突变(即GJB2、GJB6和线粒体DNA中的突变)在来自尼日利亚且无后天性病理或综合征表现证据的听力损失(HL)患者中的频率。此外,我们回顾了SSA地区耳聋遗传学的文献。
我们评估了居住在尼日利亚郊区城市伊巴丹的81名来自约鲁巴部落的非亲缘耳聋先证者的耳聋病因。如果患者的病史无环境因素导致耳聋的情况且体格检查未发现综合征证据,则对其进行基因检测。对GJB2的两个外显子和1555A>G突变侧翼的线粒体DNA进行PCR扩增,随后进行桑格测序。通过定量PCR筛选GJB6缺失。
我们确定了44名无综合征性耳聋且无环境因素导致耳聋的先证者。研究时的年龄在8个月至45岁之间(平均=24岁),发病年龄为先天性或语言前(<2岁)的有37名(84%)先证者,语言后发病的有7名(16%)先证者。其中,35名先证者是其家庭中唯一受影响的成员(单纯病例),而9例中有至少两名受影响家庭成员(多重病例)。分子分析在所研究的44名先证者中均未显示出致病变异。
在尼日利亚这一初始耳聋队列中未发现GJB2、GJB6和线粒体DNA 1555A>G突变。这使得在该人群中寻找HL病因的其他基因变得势在必行。